Re-irradiation for recurrent head and neck cancer: Freedom from cancer recurrence rate. Impact of pre-treatment anemia on survival in locally advanced head neck squamous cell carcinomas treated with ...
The discovery of cancer biomarkers is a critical component to improving patient outcomes. Key biomarkers not only determine what drives tumor growth, they also facilitate the development of treatment ...
The visual nature of head and neck cancer calls for treatment strategies that will minimize toxicities related to radiation therapy. Advances in precision radiation techniques, supportive care, and ...
A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to ...
SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in AI-driven medical imaging analysis and coordinated care, has received FDA 510(k) clearance for Lumina 3D™ by RapidAI—an industry-first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results